RE: Cryptocurrency: Spurring Financial Innovation

As you mentioned medical research, one has to find very patient investors as research and development cycles in this industry are far longer than in the IT sector. I think the very fast development in the silicon valley and the promis to get rich quickly is gaining the immense amounts of risk capital that is put into these projects. However, given the thread of chronic diseases and and the very personal relation an individual may have with that condition, there is definitely a group willing to invest also over a long (and uncertain) run. The interesting thing is that we have a lot of drug-candidates that failed to prove efficacy due to improper selection of patients (fallen angels), that may have much better chances with prior genetic testing or other now available biomarkers, but simply lack the additional money needed to clinical test again (because of the expired patent situation.) Fund raising by tokenization within the population in need of the drug, may be an interesting approach, if enough people in the token-ecosystem.

H2
H3
H4
3 columns
2 columns
1 column
1 Comment
Ecency